Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Péter Stella
Observed names:
P Stella,
P. Stella,
PETER STELLA,
Peter Stella,
Stella, Peter,
Stella, Péter
show all 6
Observed institutions:
Boehringer Ingelheim (Germany),
University of Pittsburgh,
Sanofi (France),
NYU Langone Health,
Novo Nordisk (United Kingdom),
Sanofi (Hungary),
Szent Imre Egyetemi Oktatókórház,
New York University
show all 8
ORCID:
0009-0001-4157-0400
Observed ORCID:
0009-0001-4157-0400
OpenAlex ID:
A5102336845
More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT Trial
2018
·
Julio Rosenstock
, Alice Cheng
, et al.
·
Diabetes Care
·
196
PDF
Safety, tolerability and effects on cardiometabolic risk factors of empagliflozin monotherapy in drug-naïve patients with type 2 diabetes: a double-blind extension of a Phase III randomized controlled trial
2015
·
On behalf of the EMPA-REG EXTEND™ MONO investigators
, Michael Roden
, et al.
·
Cardiovascular Diabetology
·
127
PDF
Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in E urope and the USA
2017
·
Dídac Mauricio
, Luigi Meneghini
, et al.
·
Diabetes Obesity and Metabolism
·
114
PDF
Empagliflozin as Add-on Therapy to Pioglitazone With or Without Metformin in Patients With Type 2 Diabetes Mellitus
2015
·
Christopher S. Kovacs
, Veeraswamy Seshiah
, et al.
·
Clinical Therapeutics
·
113
Cardiovascular autonomic neuropathy (expiration and inspiration ratio) in type 1 diabetes
2000
·
Peter Stella
, Demetrius Ellis
, et al.
·
Journal of Diabetes and its Complications
·
80
Urinary NGAL Marks Cystic Disease in HIV-Associated Nephropathy
2009
·
Neal Paragas
, Thomas L. Nickolas
, et al.
·
Journal of the American Society of Nephrology
·
51
The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real‐world setting
2019
·
Luigi F. Meneghini
, Didac Mauricio
, et al.
·
Diabetes Obesity and Metabolism
·
37
PDF
Late diabetes complications and non-dipping phenomenon in patients with Type 1 diabetes
2005
·
Peter Stella
, Adam Gy Tabak
, et al.
·
Diabetes Research and Clinical Practice
·
31
Efficacy and Safety of iGlarLixi, Fixed-Ratio Combination of Insulin Glargine and Lixisenatide, Compared with Basal-Bolus Regimen in Patients with Type 2 Diabetes: Propensity Score Matched Analysis
2019
·
Ádám G. Tabák
, John Anderson
, et al.
·
Diabetes Therapy
·
26
Treatment Dosing Patterns and Clinical Outcomes for Patients with Type 2 Diabetes Starting or Switching to Treatment with Insulin Glargine (300 Units per Milliliter) in a Real-World Setting: A Retrospective Observational Study
2018
·
Shaloo Gupta
, Hongwei Wang
, et al.
·
Advances in Therapy
·
24
PDF
Association between central adiposity and multimetabolic syndrome in a special cohort of women with prior gestational diabetes.
1999
·
Z Kerényi
, P Stella
, et al.
·
Diabetes Care
·
17
Association between cardiovascular autonomic neuropathy and multimetabolic syndrome in a special cohort of women with prior gestational diabetes mellitus.
1999
·
Z Kerényi
, P Stella
, et al.
·
PubMed
·
8
Association between socioeconomic factors and the metabolic syndrome in women with prior gestational diabetes mellitus.
2000
·
Z Kerényi
, A G Tabák
, et al.
·
Diabetes Care
·
7
Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal–Bolus Insulin: Phase 4 OPTIMIZE Study
2020
·
Chantal Mathieu
, S. John Weisnagel
, et al.
·
Diabetes Therapy
·
6
PDF
Association of Patient Profile with Glycemic Control and Hypoglycemia with Insulin Glargine 300 U/mL in Type 2 Diabetes: A Post Hoc Patient-Level Meta-Analysis
2018
·
Stephen M. Twigg
, Javier Escalada
, et al.
·
Diabetes Therapy
·
6
PDF
Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice‐daily basal insulin to once‐daily insulin glargine 300 U/mL or insulin glargine 100 U/mL ( EDITION 1 and EDITION 2 subgroup analysis)
2017
·
Ronan Roussel
, Michael C. d'Emden
, et al.
·
Diabetes Obesity and Metabolism
·
6
PDF
The IDEAL (Insulin therapy DE-intensificAtion with iglarLixi) Randomised Controlled Trial—Study Design and Protocol
2024
·
Peter Novodvorský
, Lenka Thieme
, et al.
·
Diabetes Therapy
·
5
PDF
Similar Glycemic Control and Less or Comparable Hypoglycemia with Insulin Glargine 300 U/mL (Gla-300) vs. Degludec 100 U/mL (IDeg-100) in Insulin-Naïve T2DM on Antihyperglycemic Drugs ± GLP-1 RAs—The BRIGHT Randomized Study
2018
·
ALICE Y.Y. CHENG
, JULIO ROSENSTOCK
, et al.
·
Diabetes
·
5
Pharmaceutical pricing, cost containment and new treatments for rare diseases in children
2014
·
Peter Stella
, Gabrielle Gold-von Simson
·
Orphanet Journal of Rare Diseases
·
5
PDF
Insulin Glargine 300 U/mL and Insulin Glulisine Treatment in Patients with Type 2 Diabetes: A Non-Interventional Study of Effectiveness in Routine Clinical Practice
2020
·
Tibor Hidvégi
, Zoltán Balogh
, et al.
·
Diabetes Therapy
·
3
PDF
Effectiveness of Insulin Glargine U300 Used as Part of Basal Bolus Therapy in People with T2DM—Toujeo 6 Months Real-World Data From Hungary
2018
·
TIBOR HIDVEGI
, PETER STELLA
·
Diabetes
·
2
The effect of concomitant DPPIVi use on glycaemic control and hypoglycaemia with insulin glargine 300 U/mL (Gla-300) versus insulin glargine 100 U/mL (Gla-100) in people with type 2 diabetes: A patient-level meta-analysis of EDITION 2 and 3
2018
·
Jean-François Yale
, Jeremy Hodson Pettus
, et al.
·
PLoS ONE
·
2
PDF
637-P: Effectiveness of Fixed Ratio Combination of IGlarLixi in People with Type 2 Diabetes Mellitus: Experience from Routine Clinical Practice
2021
·
JANOS T. KIS
, GABOR NAGY
, et al.
·
Diabetes
·
1
1105-P: Impact of Switching from Twice-Daily Basal Insulin (BI) to Once-Daily Insulin Glargine 300 U/mL (Gla-300) in Patients with Type 1 Diabetes (T1DM): Phase 4 Optimize Study
2019
·
CHANTAL MATHIEU
, PETER STELLA
, et al.
·
Diabetes
·
1
Comment and Reply on:Relative efficacy/effectiveness and relative costs of treatment with insulin glargine and insulin detemir
2007
·
Nick Freemantle
, Peter Stella
, et al.
·
Current Medical Research and Opinion
·
1
PDF
Show more works
View as search
Works count:
47
Citation count:
875
H-index:
11
I10-index:
11
Year
Topic
Type
